Brief Information of the Cell Line and Protein
Cell Line ID: CL000063 , Hep-G2
Synonyms
HEP-G2
Hep G2
HEP G2
HepG2
HEPG2
Category Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0027
Protein ID: PT06095 , Hepatic sodium/bile acid cotransporter
Gene Name SLC10A1
Organism Homo sapiens, Human
Protein Classification Transporter
Uniprot ID Q14973
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000063  Protein ID: PT06095
 
Compound ID Compound Name Compound Formula
CP0531180
2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
   Show/Hide
C50H84N2O8S
 1
1
IC50 = 0.3 nM
   TI
   LI
   LO
   TS
CP0418499
2-[[(4R)-4-[(3R,5R,7S,8R,9S,10S,13R,14S,17R)-7-hydroxy-3-[5-[[(3R,5R,7S,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-5-oxo-5-(2-sulfoethylamino)pentan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-5-oxopentanoyl]oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
   Show/Hide
C57H94N2O14S2
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0418501
2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-7-hydroxy-3-[[5-[[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-5-oxo-5-(2-sulfoethylamino)pentan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]amino]-5-oxopentanoyl]amino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
   Show/Hide
C57H96N4O12S2
 3
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
2
IC50 = 58.33 nM
   TI
   LI
   LO
   TS
3
IC50 = 8348 nM
   TI
   LI
   LO
   TS
CP0418503
(1S,3S,4R,5S,8R,9S,12R,13R,24R,25R,28S,29R,32S,33R,34S,36S,37S,40R,48R,51S)-3,34-dihydroxy-8,13,24,29,37,51-hexamethyl-17,20,41,47-tetrazanonacyclo[46.3.1.136,40.04,9.05,51.08,12.025,29.028,33.032,37]tripentacontane-16,21,42,46-tetrone
   Show/Hide
C55H90N4O6
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0494215
2-[[(4R)-4-[(3R,5R,7S,8R,9S,10S,13R,14S,17R)-3-[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]oxy-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
   Show/Hide
C50H83NO9S
 2
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
2
IC50 = 36.2 nM
   TI
   LI
   LO
   TS
CP0494216
2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-7-hydroxy-3-[4-[[(3R,5R,7S,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-5-oxo-5-(2-sulfoethylamino)pentan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxymethyl]triazol-1-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
   Show/Hide
C55H91N5O11S2
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0527606
(1R,8R,11S,12R,14S,15R,16S,19R,20S,23R,24R,35R,36R,39S,40R,43S,44R,45S,47S,48S)-14,45-dihydroxy-11,19,24,35,40,48-hexamethyl-27,32-dioxo-7-oxa-2,3,4,28,31-pentazadecacyclo[45.3.1.12,5.18,12.011,16.015,20.019,23.036,40.039,44.043,48]tripentaconta-3,5(53)-diene-29-carboxylic acid
   Show/Hide
C54H85N5O7
 3
1
IC50 = 17.9 nM
   TI
   LI
   LO
   TS
2
IC50 = 109.2 nM
   TI
   LI
   LO
   TS
3
IC50 = 167.2 nM
   TI
   LI
   LO
   TS
CP0527605
2-[[(1R,8R,11S,12R,14S,15R,16S,19R,20S,23R,24R,35R,36R,39S,40R,43S,44R,45S,47S,48S)-14,45-dihydroxy-11,19,24,35,40,48-hexamethyl-27,32-dioxo-7-oxa-2,3,4,28,31-pentazadecacyclo[45.3.1.12,5.18,12.011,16.015,20.019,23.036,40.039,44.043,48]tripentaconta-3,5(53)-diene-29-carbonyl]amino]ethanesulfonic acid
   Show/Hide
C56H90N6O9S
 3
1
IC50 = 23.5 nM
   TI
   LI
   LO
   TS
2
IC50 = 54 nM
   TI
   LI
   LO
   TS
3
IC50 = 81.5 nM
   TI
   LI
   LO
   TS
CP0548285
2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3-[4-[(3R)-3-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl]triazol-1-yl]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
   Show/Hide
C51H84N4O7S
 2
1
IC50 = 24.5 nM
   TI
   LI
   LO
   TS
2
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0550784
(1R,8R,11S,12R,14S,15R,16S,19R,20S,23R,24R,35R,36R,39S,40R,43S,44R,45S,47S,48S)-14,45-dihydroxy-11,19,24,35,40,48-hexamethyl-7-oxa-2,3,4,28,31-pentazadecacyclo[45.3.1.12,5.18,12.011,16.015,20.019,23.036,40.039,44.043,48]tripentaconta-3,5(53)-diene-27,32-dione
   Show/Hide
C53H85N5O5
 1
1
IC50 = 37.5 nM
   TI
   LI
   LO
   TS